Citadel Advisors Increases Stake in Intuitive Surgical
Citadel Advisors, led by billionaire CEO Ken Griffin, boosted its stake in Intuitive Surgical (NASDAQ: ISRG) by 30.3% during the first quarter of 2023. This decision comes despite the healthcare firm’s stock dropping by 20% in the past year due to increased competition, lower margins on certain products, and tariffs affecting financial results. Intuitive Surgical is considered well-positioned in the robotic-assisted surgery market, with a significant addressable market ahead.
In the same quarter, Citadel Advisors sold 2.9 million shares of Nvidia and six million shares of Amazon, reallocating that capital into Intuitive Surgical, which it views as an attractive investment opportunity. The company’s continued revenue growth and potential leveraging of artificial intelligence in healthcare could enhance its competitive advantage, despite current hurdles.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
